Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children

Journal of Cataract and Refractive Surgery

Volumn 25, Issue 3, 1999, Pages 357-362

  Klais, Christina M ^a   Hattenbach, Lars Olof ^a   Steinkamp, Gerd W K ^a   Zubcov, Alina A ^a   Kohnen, Thomas ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRISOL; PREDNISOLONE ACETATE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CATARACT EXTRACTION; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032970044     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(99)80083-2     Document Type: Article

References (25)

1. Crouch ER Jr, Pressman SH, Crouch ER. Posterior chamber intraocular lenses: long-term results in pediatric cataract patients. J Pediatr Ophthalmol Strabismus 1995; 32:210-218
2. Vajpayee RB, Angra SK, Titiyal JS, et al. Pseudophakic pupillary-block glaucoma in children. Am J Ophthalmol 1991; 111:715-718
3. Gimbel HV, Ferensowicz M, Raanan M, DeLuca M. Implantation in children. J Pediatr Ophthalmol Strabismus 1993; 30:69-79
4. Koch DD, Kohnen T. Retrospective comparison of techniques to prevent secondary cataract formation after posterior chamber intraocular lens implantation in infants and children. J Cataract Refract Surg 1997; 23:657-663
5. Zetterström C, Kugelberg U, Oscarson C. Cataract surgery in children with capsulorhexis of anterior and posterior capsules and heparin-surface-modified intraocular lenses. J Cataract Refract Surg 1994; 20:599-601
6. Dahan E, Salmenson BD. Pseudophakia in children: precautions, technique, and feasibility. J Cataract Refract Surg 1990; 16:75-82
7. Buckley EG, Klombers LA, Seaber JH, et al. Management of the posterior capsule during pediatric intraocu-lar lens implantation. Am J Ophthalmol 1993; 115:722-728
8. Williams GA, Lambrou FH, Jaffe GA, et al. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator. Arch Ophthalmol 1988; 106:1055-1058
9. Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981; 256:7035-7041
10. Pennica D, Holmes WE, Kohr WJ, et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 1983; 301:214-221
11. Brady KM, Atkinson CS, Kilty LA, Hiles DA. Cataract surgery and intraocular lens implantation in children. Am J Ophthalmol 1995; 120:1-9
12. Nishi O. Fibrinous membrane formation on the posterior chamber lens during the early postoperative period. J Cataract Refract Surg 1988; 14:73-77
13. Miyake K. The significance of inflammatory reactions following cataract extraction and intraocular lens implantation. J Cataract Refract Surg 1996; 22:759-763
14. Zetterström C, Kugelberg U, Lundgren B, Syrén-Nordqvist S. After-cataract formation in newborn rabbits implanted with intraocular lenses. J Cataract Refract Surg 1996; 22:85-88
15. Konnen T, Dick B, Hessemer V, et al. Effect of heparin in irrigating solution on inflammation following small incision cataract surgery. J Cataract Refract Surg 1998; 24:237-243
16. Verstraete M, Bleifeld W, Brower RW, et al. Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction. Lancet 1985; 2:965-969
17. Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. J Biol Chem 1982; 257:2912-2919
18. Moon J, Chung S, Myong Y, et al. Treatment of postcataract fibrinous membranes with tissue plasminogen activator. Ophthalmology 1992; 99:1256-1259
19. Dabbs CK, Aaberg TM, Aguilar HE, et al. Complications of tissue plasminogen activator therapy after vitrectomy for diabetes. Am J Ophthalmol 1990; 110:354-360
20. Starck T, Hopp L, Held KS, et al. Low-dose intraocular tissue plasminogen activator treatment for traumatic total hyphema, postcataract, and penetrating keratoplasty fibrinous membranes. J Cataract Refract Surg 1995; 21:219-224
21. Johnson MW, Olsen KR, Hernandez E, et al. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 1990; 108:259-263
22. Doughman DJ, Olson GA, Nolan S, Hajny RG. Experi-mental band keratopathy. Arch Ophthalmol 1969; 81:264-271
23. Wollensak G, Meyer JH, Löffler KU, Funk J. Bandförmige Keratopathie nach Behandlung der postoperativen Fibrinreaktion mit Gewebeplasminogenaktivator. Klin Monatsbl Augenheilkd 1996; 209:43-46
24. Althaus C, Schelle C, Sundmacher R. Akute bandförmige Keratopathie nach intraokularer Fibrinolyse mit rekombinantem Tissue-Plasminogen-Aktivator (rt-PA). Klin Monatsbl Augenheilkd 1996; 209:318-321
25. Tugal-Tutkun I, Havrlikova K, Power WJ, Foster CS. Changing patterns in uveitis of childhood. Ophthalmology 1996; 103:375-383